Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,405 shares of the medical research company’s stock after selling 668 shares during the […]
Exact Sciences Corp. (EXAS) just unveiled an update. Dr. Freda Lewis-Hall, a board member of Exact Sciences Corporation, plans to retire immediatel...
New blood tests measure “signals” in the blood to help detect cancer. Experts say more study is needed to determine if the new tests save lives
The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.
In this article, we discuss the 10 best performing biotech ETFs in 2024.